Berman Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $309K | Buy |
4,438
+1,744
| +65% | +$121K | 0.05% | 197 |
|
|
2021
Q2 | $185K | Buy |
2,694
+728
| +37% | +$50K | 0.03% | 249 |
|
|
2021
Q1 | $126K | Buy |
1,966
+455
| +30% | +$29.2K | 0.03% | 257 |
|
|
2020
Q4 | $88K | Buy |
1,511
+7
| +0.5% | +$408 | 0.02% | 275 |
|
|
2020
Q3 | $94K | Sell |
1,504
-638
| -30% | -$39.9K | 0.03% | 235 |
|
|
2020
Q2 | $163K | Sell |
2,142
-294
| -12% | -$22.4K | 0.04% | 164 |
|
|
2020
Q1 | $181K | Buy |
2,436
+911
| +60% | +$67.7K | 0.06% | 131 |
|
|
2019
Q4 | $98K | Buy |
1,525
+66
| +5% | +$4.24K | 0.03% | 220 |
|
|
2019
Q3 | $92K | Sell |
1,459
-109
| -7% | -$6.87K | 0.03% | 219 |
|
|
2019
Q2 | $105K | Buy |
1,568
+192
| +14% | +$12.9K | 0.03% | 202 |
|
|
2019
Q1 | $89K | Buy |
1,376
+285
| +26% | +$18.4K | 0.03% | 205 |
|
|
2018
Q4 | $67K | Buy |
+1,091
| New | +$67K | 0.03% | 222 |
|